🇺🇸 FDA
Pipeline program

metoclopramide or mosapride

KY20162086-2

Unknown small_molecule terminated

Quick answer

metoclopramide or mosapride for Severe Stroke is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Severe Stroke
Phase
Unknown
Modality
small_molecule
Status
terminated

Clinical trials